Drug therapy, lifestyle modification and blood pressure control in a primary care facility, south of Johannesburg, South Africa: an audit of hypertension management

References

• World Health Organization. World Health Report 2002: reducing risks, promoting healthy life style [document online]. c2002 [cited 2010 Mar 13]. Available from: http://www.who.int/whr/2002/en/2002flierANG.pdf
   Google Scholar
• Gaziano T, Reddy KS, Paccaud F, Horton S. Cardiovascular disease. In: Jamison D, Breman JG, Mesham AR, et al, eds. Disease control priorities in developing countries. 2nd edition. New York: Oxford University Press and the World Bank, 2006; p. 645–662.
   Google Scholar
• Bradshaw D, Nannan N, Laubscher R, et al. South African national burden of disease study 2000: estimates of provincial mortality. Cape Town: Medical Research Council; 2004.
   Google Scholar
• Department of Health, Medical Research Council, ORC Macro. South Africa Demography and Health Survey 2003 [document online]. c2003 [cited 2011 Mar 9). Available from: http://www.mrc.ac.za/bod/sadhs2003part1.pdf
   Google Scholar
• Ker JA. Essential hypertension. CME 2006;24:176–182.
   Google Scholar
• Seedat YK, Croasdale MA, Milne FJ, et al. South African hypertension guideline 2006. S Afr Med J. 2006;96:337–361.
   PubMed Web of Science ®Google Scholar
• Appel LJ, Champagne CM, Harsha DW, et al. Effects of comprehensive life style modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003;289:2083–2093.
   PubMed Web of Science ®Google Scholar
• Rayner B. Hypertension: detection and management in South Africa. Nephron Clin Pract. 2010;116:c269–c273.
   PubMed Web of Science ®Google Scholar
• Steyn K, Levitt NS, Patel M, et al. Hypertension and diabetes: poor care for patients at community health centres. S Afr Med J. 2008;98:618–622.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572.
   PubMed Web of Science ®Google Scholar
• Hara K, Kadowaki T. How controlling blood pressure might matter. Circ J. 2009;73:2208–2209.
   PubMed Web of Science ®Google Scholar
• Wenzel RP editor. Assessing quality health care. Baltimore: William and Wilkins; 1992.
   Google Scholar
• Irvine D, Irvine S. Making sense of audits. 2nd edition. Oxford: Radcliffe Medical Press; 1997.
   Google Scholar
• National Institute of Health and Clinical Excellence. Principles for best practice in clinical audit. Oxford: Radcliffe Medical Press; 2002.
   Google Scholar
• Whitworth JA, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization WHO/International Society of Hypertension statement on management of hypertension. J Hypertens. 2003;21:1983–1992.
   Google Scholar
• Chalmers J, Arima H. Management of hypertension: evidence from the Blood Pressure Lowering Treatment Trialists Collaboration and from major clinical trials. Pol Arch Med Wewn. 2009;119:373–380.
   PubMed Web of Science ®Google Scholar
• Sample size calculator. Raosoft®[homepage on the Internet]. c2004 [cited 2010 March 13]. Available from: http://www.raosoft.com/samplesize.html
   Google Scholar
• Appendix IV. In: Joubert G, Ehrlich R, Katzenellenbogen J, Abdool Karim S, editors. Epidemiology: a research manual for South Africa. 2nd ed. New York: Oxford University Press, 2006; p. 346–348.
   Google Scholar
• Peer N, Dennison CR, Lombard C, et al. Target organ damage in black South African patients with hypertension. J Clin Hypertens. 2006;8:A174.
   Google Scholar
• Rayner B, Blockman M, Baines D, Trinder Y. A survey of hypertensive practices at two community health centres in Cape Town. S Afr Med J. 2007;97:280–284.
   PubMed Web of Science ®Google Scholar
• Steyn K, Levitt N, Fourie J, et al. Treatment status and experiences of hypertensive patients at a large health centre in Cape Town. Ethn Dis. 1999;9:441–450.
   PubMedGoogle Scholar
• Brewster LM, Van Montfrans GA, Kleijnem J. Systematic review: antihypertensive drug therapy in black patients. Ann Intern Med. 2004;141:614–627.
   PubMed Web of Science ®Google Scholar
• Cheung BMY, Ong KL, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001–2002. J Clin Hypertens. 2006;8:93–98.
   PubMedGoogle Scholar
• Buckley B, Shanahan E, Colwell N, et al. Blood pressure control in hypertensive patients in Irish primary care practices. J Clin Hypertens. 2009;11:432–440.
   PubMed Web of Science ®Google Scholar
• Dennison CR, Peer N, Steyn K, et al. Determinants of hypertension care and control among peri-urban black South Africans: the HiHi study. Ethn Dis. 2007;17:484–491.
   PubMed Web of Science ®Google Scholar
• Steyn K, Bradshaw D, Norman R, Laubscher R. Determinants and treatment of hypertension in South Africans: the first demographic and health survey. S Afr Med J. 2008;98:376–380.
   PubMed Web of Science ®Google Scholar
• Fiscella K, Holt K. Racial disparity in hypertension control: tallying the death toll. Ann Fam Med. 2008;6:497–502.
   PubMed Web of Science ®Google Scholar
• Cene CW, Roter D, Carson KA, et al. The effect of patient race and blood pressure control on patient-physician communication. J Gen Intern Med. 2009;24:1057–1064.
   PubMed Web of Science ®Google Scholar
• Charlton KE, Steyn K, Levitt NS, et al. A food-based dietary strategy lowers blood pressure in a low socio-economic setting: a randomized study in South Africa. Public Health Nutr. 2008;11:1397–1406.
   PubMed Web of Science ®Google Scholar
• Van Zyl S, Van der Merwe LJ, Walsh CM, et al. A risk profile for chronic lifestyle diseases in three Free State towns. S Afr Fam Pract. 2010;52:72–76.
   Google Scholar
• Puoane T, Steyn K, Bradshaw Laubscher R, et al. Obesity in South Africa: the South African demographic and health survey. Obes Res. 2002;10:1038–1048.
   PubMedGoogle Scholar
• Opie LH, Seedat YK. Hypertension in sub-Saharan African population. Circulation 2005;112:3562–3568.
   PubMed Web of Science ®Google Scholar
• Steele LS, Dewa CS, Lin E, Lee KLK. Education level, income level and mental health services use in Canada: associations and policy implications. Healthc Policy. 2007;3:96–106.
   PubMedGoogle Scholar
• Ahmed S, Creanga AA, Gillespie DG, Tsui AO. Economic status, education and empowerment: implications for maternal health service utilization in developing countries. PLoS One. 2010;5:e11190.
   PubMed Web of Science ®Google Scholar
• Murphree DD, Thelen SM. Chronic kidney disease in primary care. J Am Board Fam Med. 2010;23:542–550.
   PubMed Web of Science ®Google Scholar
• Ramani GV, Uber PA, Mehra MR. Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc. 2010;85:180–195.
   PubMed Web of Science ®Google Scholar
• ALLHAT officers and coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin- converting enzyme inhibitor or calcium channel blocker vs. diuretic. JAMA. 2002;288:2981–2997.
   PubMed Web of Science ®Google Scholar
• PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033–1041.
   PubMed Web of Science ®Google Scholar
• De Jesus RS, Chaudhry R, Leutink DJ, et al. Effects of efforts to intensify management on blood pressure control among patients with type 2 diabetes mellitus and hypertension: a pilot study. Vasc Health Risk Manag. 2009;5:705–711.
   PubMedGoogle Scholar
• Scheen AJ, Paquot N, Lefebvre PJ. United Kingdom Prospective Diabetic Study (UKPDS): 10 years later. Rev Med Liege. 2007;63:624–629.
   Google Scholar
• ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial. Lancet 2007;370:829–840.
   PubMed Web of Science ®Google Scholar
• Buse JB, The ACCORD Study Group. Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. Am J Cardiol. 2007;99:S21–S33.
   PubMed Web of Science ®Google Scholar
• Brugts JJ, Ninomiya T, Boersma E, et al. The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA and PROGRESS trials. Eur Heart J. 2009;30:1307–1309.
   PubMed Web of Science ®Google Scholar
• Sareli P Radevski IV, Valtchanova ZP, et al. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. Arc Intern Med. 2001;161:965–971.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145–153.
   PubMed Web of Science ®Google Scholar
• Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive agent of amilodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005;366:895–906.
   PubMed Web of Science ®Google Scholar